Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1997-05-14
1999-10-05
Housel, James C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4241841, 4241471, 4242571, 4241931, 4241971, 4242781, A61K 39112
Patent
active
059619856
ABSTRACT:
A combination vaccine, with methods of preparation and treatment, for protection against Gram negative bacterial diseases. The vaccine includes a killed suspension of a bacterial mutant from the taxonomic family Enterobacteriaceae, a B-lymphocyte proliferating immune modulator, and a protein and lipid binding adjuvant. A hyperimmune serum for treating diseased animals is prepared by vaccinating a donor animal with the combination vaccine and then preparing clot serum containing antigen specific antibodies. The mutant is ATCC No. 53000 and is produced by ionizing radiation of Salmonella enteritidis. The immune modulator is a detoxified extract of lipopolysaccharide and is useful with many antigens to enhance primary immune response.
REFERENCES:
patent: 3075883 (1963-01-01), Scherr et al.
patent: 4029762 (1977-06-01), Galanos et al.
patent: 4148877 (1979-04-01), Choay et al.
patent: 4242270 (1980-12-01), Ayme et al.
patent: 4327082 (1982-04-01), Armitage
patent: 4328210 (1982-05-01), Kucera
patent: 4335107 (1982-06-01), Snoeyenbos et al.
patent: 4338298 (1982-07-01), Myers
patent: 4343792 (1982-08-01), Gouet et al.
patent: 4350684 (1982-09-01), Pardon et al.
patent: 4404186 (1983-09-01), Ron
patent: 4491660 (1985-01-01), Gendrich et al.
patent: 4495096 (1985-01-01), Wissler
patent: 4530831 (1985-07-01), Lutticken et al.
patent: 4530832 (1985-07-01), Goodnow et al.
patent: 4567041 (1986-01-01), Likhite
patent: 4569840 (1986-02-01), Kit
patent: 4571336 (1986-02-01), Houck et al.
patent: 4582790 (1986-04-01), Auerbach
patent: 4582798 (1986-04-01), Brown et al.
patent: 4762712 (1988-08-01), Stolle et al.
patent: 4789544 (1988-12-01), Nelson et al.
patent: 5179018 (1993-01-01), Bogard, Jr. et al.
Acres, et al. "Antigen-Extinction Profile in Pregnant Cows . . . "; Am. J. Vet. Res. vol. 43, No. 4, pp. 569-575, Apr. 1982.
Alving et al. "Mitogenic Activities of Lipid A and Liposome-Associated Lipid A: Effects of Epitope Density", Reviews of Infectious Diseases, vol. 6, No. 4, pp. 493-496, Jul.-Aug. 1984.
Chedid et al. "Immunologie--Activities Edjuvante et Mitogene de Lipopolysaccharides Detoxifies", C.R. Acad. Sc. Paris, t. 280, 3 Mars 1975.
Crosa et al. "Molecular Relationships Among the Salmonelleae", J. of Bacteriology, vol. 115, No. 1, pp. 307-315, Jul 1973.
Davis et al. "Microbiology", 3rd Edition, pp. 436, 437, 447 and 448.
Eisenstein "Evidence for O-Antigens . . . Prepared from Salmonella", Infection and Immunity, vol. 12, No. 2, pp. 364-377, Aug. 1975.
Eisenstein "Immunity To Experimental Salmonella Infection: . . . In C3H/HeJ and CD-1 Mice.sup.1 ", The Journal of Immunology, vol. 121, No. 3, pp. 1010-1014, Sep. 1978.
Fauci "Host-Defense Mechanisms Against Infection", Current Concepts, pp. 18-27.
Gaffin "Prophylaxis and Therapy With Anti-Endotoxin . . . ", Proceedings of American Assoc. of Equine Practitioners, 1982, Atlanta, Georgia.
Girotti et al. "Effects of Immunization On Cardiopulmonary Alterations Of Gram-Negative Endotoxemia", Journal of Applied Physiology; Respiration, environment, exercise Physiology 56(3); 582-589, 1984.
Goodman et al. "Selective Interaction Between Lymphocytes and Lipid A Subunits in Lipopolysaccharide Macromolecular Aggregates", Review of Infectious Diseases, vol. 6, No. 4, pp. 511-518, Jul.-Aug. 1984.
Hodgin et al., Infection (1976) 4(2) 5-10 Abstract.
Johns et al., Biol. Abs. 64:50388, 1977.
Johns et al. "Immunization With Rough Mutants of Salmonella Minnesota IV Protection by Antisera to O and Rough Antigens Against Endotoxin", Journal of Infectious Disease, vol. 147, No. 1, Jan. 1983.
Johnston et al. "Resistance of Neonatal Calves Given Clostrum Diet . . . ", Am. J. Vet. Res., vol. 38, No. 9, pp. 1323-1326, Sep. 1977.
Kawakami et al. "Experimental Salmonellosis", Journal of Bacteriology, vol. 92, No. 6, pp. 1585-1589, 1966.
Kwapinski, "Preparation of Antigens", Methodology of Immunochemical And Immunological Research, pp. 74, 80-81.
Kenney et al. "Antibody Response and Protection Induced by Immunization with Smooth and Rough Strains in Experimental Salmonellosis", Journal of Bacteriology, vol., 95, pp. 406-417, Feb. 1968.
Luderitz et al., "Immunochemistry of O and R Antigens of Salmonella and Related Enterobacteriaceae", Bacteriological Reviews, vol. 30, No. 1, pp. 192-255, Mar. 1966.
McCabe et al. Prog. Clin., Biol. Res., 47,107-17, (1980) Medline Abst. No. 81141080.
McCabe, "Immunization With R Mutants of S. Minnesota", Journal of Immunology, vol. 108, No. 3, pp. 601-610, Mar. 1972.
Moller et al., "Section II: Immunology", Bacterial Lipopolysaccharides The Chemistry, Biology, and Clinical Significance of Endotoxins, pp. 44-48.
Makela et al., "Role of O-antigen (Lipopolysaccharide) Factors in the Virulence of Salmonella", Bacterial Lipopolysaccharides The Chemistry, Biology, and Clinnical Significance of Endotoxins, pp. 73-77.
Morris, D.C., et al., Proceedings of the Conference of Research Workers and Animal Diseases--64th Annual Meeting, Chicago, Ill. Nov. 1983, Abstract 190.
Myers, L.L., "Passive Protection of Calves Against Experimentally Induced and Naturally Occurring Enteric Colibacillosis", Am. J. Vet. Res. vol. 41, No. 12, pp. 1952-1956, 1980.
Myers, L.L., "Vaccination of Cows with an Escherichia coli Bacterin for the Prevention of Naturally Occurring Diarrheal Disease in Their Calves", Am. J. Vet. Res. vol. 37, No. 7, pp. 831-834, Jul. 1976.
Ribi et al., "Peptides as Requirement for Immunotherapy of the Guinea-pig Line-10 Tumor with Endotoxins", Cance Immunol. Immunother. 7, 43-58, 1979.
Biological Abstracts, vol. 79, Abstract No. 13284, 1984.
Chem. Abs., vol. 76, Abstract No. 31062v, 1972.
Chem. Abs. vol. 89, Abstract No. 195284p.
Biological Abstracts, vol. 62, Abstract No. 37306, 1976.
Biological Abstracts, 70(7):4630, Abstract No. 44015, 1980.
Smith et al., "A Preliminary Evaluation of Some Preparations of S. Typhimurium As Vaccines In Horses", The University of Georgia, pp. 211-215, Sep. 18, 1982.
Smith et al., "Aromatic-dependent Salmonella Typhimurium As Modified Live Vaccines for Calves", American Journal of Veterinary Research, vol. 45, No. 1, pp. 59-66, Jan. 1984.
Takayama et al., "Separation and Characterization of Toxic and Nontoxic Forms of Lipid A", Reviews of Infectious Diseases, vol. 6, No. 4, pp. 439-443, Jul.-Aug. 1984.
Thomson, B.V.Sc., "Equine Anti-Endotoxin Hyperimmune Serum in the Treatment of Septic Arthritis in Foals", Equine Practice-Medicine/Orthopedics 6(2): 8-10, 1984.
Tizard, "The Cellular Basis of Antibody Formation", Veterinary Immunology An Introduction, 3rd Edition, pp. 67-73, 1987.
Ward et al., "Use of a Formalin-Treated, Live Escherichia coli Vaccine in the Prevention of Neonatal Enteric Colibacillosis in Swine", JAVMA, vol. 168, No. 4, pp. 317-318, Feb. 1976.
White, "Concepts of the Mechanism of Action of Adjuvants", Immunogenicity, pp. 112-113, 1972.
Wilkinson et al., "Non-Smooth Mutants of Salmonella Typhimurium: Differentiation by Phage Sensitivity and Genetic Mapping", Journal of General Microbiology, 70, pp. 527-554, 1972.
Young et al., Cross-Protective Immunity to Gram-Negative Bacilli: Studies with Core Glycolipid of Salmonenna Minnesota and Antigens of Streptococcus Pneumoniae, Journal of Infectitious Diseases, vol. 156, pp. S174-S180, Aug. 1977.
Ziegler et al., "Treatment of Gram-Negative Bacteremia and Shock With Human Antiserum to a Mutant Escherichia Coli", New England Journal of Medicine, vol. 307, No. 20, pp. 1225-1230, Nov. 11, 1982.
"Methods In Immunology and Immunochemistry", pp. 28-31, 1967.
"Methods In Immunology and Immunochemistry", pp. 64-69, 1967.
McCabe, T. Inf. Dis., 136, 5161-6, (1977).
Morrison et al. Adv. Immunol., vol. 28, pp. 294-450 (1979).
Crosa et al. J of Bact 155:307-325 1973.
Galanos et al. International Review of Biochemistry, Biochemistry of Lipids II, vol. 14 only pp. 250, 251, 254, 255-259.
Sonnenwirth, in Microbiology 3rd Edition, Chapter 31, p. 647.
Collins et al. Infect & Immunity 6:451-458 1971.
Thomson, et al. "The Use of Equine Anti-Endotoxin Hyperimmune Serum . . . " Journal of the South African Veterinary Association 54:259-281, 1983.
Hodgin et al. 1976.
Garner Harold E.
Sprouse Ronald F.
Graser Jennifer
Housel James C.
The Curators of the University of Missouri
LandOfFree
Vaccine and serum for endotoxin associated disease immunization does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine and serum for endotoxin associated disease immunization , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine and serum for endotoxin associated disease immunization will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1168454